Science
Anthropic reports Claude AI identified novel CRISPR-like enzyme system
Researchers used hundreds of AI agents to detect an uncharacterized bacteriophage system that human scientists later tested in a lab.
The short version
- Anthropic announced that its Claude AI agents identified a novel enzyme system termed array-associated reverse transcriptases (ART) featuring CRISPR-like DNA repeat arrays.[Hacker News]
- The computational search deployed roughly 950 agents across 21 hours and 210 million tokens before human laboratory teams tested the candidate.[TechCrunch · Hacker News]
- Anthropic CEO Dario Amodei noted that a Stanford research team had previously described a somewhat similar system, leaving wider community validation as a next step.[TechCrunch]
Key facts
- Anthropic announced a new life sciences group and laboratory established in spring 2026.[TechCrunch · Hacker News]
- Claude discovered array-associated reverse transcriptases (ART), an enzyme system in bacteriophages containing a reverse transcriptase, a partner gene, and evenly spaced DNA repeats.[Hacker News]
- The computational analysis used roughly 950 agents over 21 hours and processed 210 million tokens.[TechCrunch · Hacker News]
- Human scientists conducted the subsequent laboratory experiments under biosafety level 1 and 2 standards without handling human pathogens.[TechCrunch · Hacker News]
- Although the underlying reverse transcriptase had been cataloged in a jumbo phage previously, Claude was first to flag the non-coding repeat array and an accessory protein.[Hacker News]
What remains uncertain
- Anthropic noted that the broader scientific community still needs to evaluate and validate the novelty and significance of the reported finding.[TechCrunch]
- Anthropic CEO Dario Amodei acknowledged that researchers at Stanford previously identified a biological system somewhat similar to the one Claude found.[TechCrunch]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.